• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Infectious diseases and cognition: do we have to worry?
ConclusionsTaken together, the studies examined in the present review emphasize that numerous acute and chronic infectious diseases share mechanisms that, when added to specific risk factors frequently found in older persons, contribute to considerably increase the risk of cognitive outcomes such as cognitive decline and dementia. This review may help to appreciate the role that infectious diseases play in cognitive trajectories and thus promote further investigation on the topic.
Source: Neurological Sciences - July 22, 2022 Category: Neurology Source Type: research

Uptake and Attitudes About Immunizations in People With Multiple Sclerosis
Conclusion Vaccination uptake is lower than desired in the MS population compared with existing recommendations, including for seasonal influenza. Misconceptions about the safety of vaccination in the context of MS and personal preference appear to play important roles in vaccination choices, highlighting the importance of education about these issues.
Source: Neurology Clinical Practice - August 9, 2021 Category: Neurology Authors: Marrie, R. A., Kosowan, L., Cutter, G. R., Fox, R., Salter, A. Tags: Multiple sclerosis, All epidemiology Research Source Type: research

Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?
Abstract In June 2017 the European Court of Justice (ECJ) issued a verdict on the legal assessment of the association between hepatitis B immunization and the subsequent manifestation of multiple sclerosis (MS). This led to a high level of insecurity in the medical field as well as the normal population, especially in MS patients. The aim of this article is to briefly present the evidence-based medical facts and in particular to clearly highlight the legal aspects of the abovenamed ECJ verdict. PMID: 29404651 [PubMed - as supplied by publisher]
Source: Der Nervenarzt - February 5, 2018 Category: Neurology Authors: Löbermann M, Handorn B, Winkelmann A, Reisinger EC, Hartung HP, Zettl UK Tags: Nervenarzt Source Type: research

Vaccines and MS
A study found no association between hepatitis B and human papillomavirus (HPV) vaccines and an increased risk of MS up to three years after vaccination. Medical News Today Science 2.0 Vaccination and immunisation - A to Z of MS
Source: Multiple Sclerosis Trust - October 19, 2014 Category: Neurology Source Type: news

Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
ImportanceBecause vaccinations are common, even a small increased risk of multiple sclerosis (MS) or other acquired central nervous system demyelinating syndromes (CNS ADS) could have a significant effect on public health.ObjectiveTo determine whether vaccines, particularly those for hepatitis B (HepB) and human papillomavirus (HPV), increase the risk of MS or other CNS ADS.Design, Setting, and ParticipantsA nested case-control study was conducted using data obtained from the complete electronic health records of Kaiser Permanente Southern California (KPSC) members. Cases were identified through the KPSC CNS ADS cohort bet...
Source: JAMA Neurology - December 1, 2014 Category: Neurology Source Type: research

Zika Virus Potentiates the Development of Neurological Defects and Microcephaly: Challenges and Control Strategies
Conclusions Apart West Nile virus (78), thousands of congenital microcephaly cases, fetal brain tissue damage and neurological syndromes have been associated with ZIKV infection. Unfortunately, the epidemics of this mosquito born, and a relative stable virus is on a rise. Although congenital microcephaly is a rare disorder however, due to lack of standardized diagnostic test facilities, the incidence in the geographically widespread ZIKV epidemic regions is higher. Animals studies showed that ZIKV is a neurotropic virus. It directly targets the developing embryonic brain cells by inducing apoptosis, cell-cycle arrest, and...
Source: Frontiers in Neurology - April 8, 2019 Category: Neurology Source Type: research

Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome
CONCLUSIONS: Acute lymphoblastic leukemia, vaccines against hepatitis A and meningococci can be included among antecedent factors in OMAS. Among clinical symptoms, speech problems might point to the likelihood of an underlying neoplasm in OMAS. Intravenous immunoglobulin and steroids may be chosen for initial treatment while rituximab can increase the chance of recovery in case of persistent or recurrent symptoms. The presence of relapse was associated with poor outcome.PMID:36155293 | DOI:10.1016/j.ejpn.2022.09.002
Source: European Journal of Paediatric Neurology - September 26, 2022 Category: Neurology Authors: Mira ç Yıldırım İbrahim Öncel Ömer Bektaş Gizem Tanal ı S üleyman Şahin Tezer Kutluk Serap Teber Banu Anlar Source Type: research